NODELMAN OLEG Insider Trading -- Recent SEC Form 4 Transactions
NODELMAN OLEG (CIK 1454385) reported 10 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-11-18). Recent activity: Buy ANAB (84,120 shares), Buy ANAB (152,367 shares), Buy ANAB (138,093 shares), Buy AKTS (2.3M shares), Buy AKTS (202,862 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-18 | ANAPTYSBIO, INC (ANAB) | Director | Buy | 84,120 | $3.8M |
| 2026-11-18 | ANAPTYSBIO, INC (ANAB) | Director | Buy | 152,367 | $7.0M |
| 2026-11-18 | ANAPTYSBIO, INC (ANAB) | Director | Buy | 138,093 | $6.4M |
| 2026-01-12 | Aktis Oncology, Inc. (AKTS) | Director | Buy | 2.3M | $0 |
| 2026-01-12 | Aktis Oncology, Inc. (AKTS) | Director | Buy | 202,862 | $0 |
| 2026-01-12 | Aktis Oncology, Inc. (AKTS) | Director | Buy | 128,506 | $0 |
| 2026-01-12 | Aktis Oncology, Inc. (AKTS) | Director | Buy | 2.1M | $37.4M |
| 2026-01-12 | Aktis Oncology, Inc. (AKTS) | Director | Buy | 144,443 | $2.6M |
| 2025-06-27 | Zymeworks Inc. (ZYME) | Director | Buy | 5.1M | $0 |
| 2025-06-27 | Zymeworks Inc. (ZYME) | Director | Sell | 41 | $521 |
Source: SEC Form 4 filings · as of 2026-11-18